Terms: = Pancreatic cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Clinical Outcome
5 results:
1. Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma.
Croft W; Pearce H; Margielewska-Davies S; Lim L; Nicol SM; Zayou F; Blakeway D; Marcon F; Powell-Brett S; Mahon B; Merard R; Zuo J; Middleton G; Roberts K; Brown RM; Moss P
Elife; 2023 Jun; 12():. PubMed ID: 37350578
[TBL] [Abstract] [Full Text] [Related]
2. Combining clinicopathological predictors and molecular biomarkers in the oncogenic K-RAS/Ki67/HIF-1α pathway to predict survival in resectable pancreatic cancer.
Qin R; Smyrk TC; Reed NR; Schmidt RL; Schnelldorfer T; Chari ST; Petersen GM; Tang AH
Br J Cancer; 2015 Feb; 112(3):514-22. PubMed ID: 25584484
[TBL] [Abstract] [Full Text] [Related]
3. Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1/2 activation.
Hong B; Lui VW; Hui EP; Ng MH; Cheng SH; Sung FL; Tsang CM; Tsao SW; Chan AT
Invest New Drugs; 2011 Jun; 29(3):401-10. PubMed ID: 20013349
[TBL] [Abstract] [Full Text] [Related]
4. High expression of hif1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF.
Hoffmann AC; Mori R; Vallbohmer D; Brabender J; Klein E; Drebber U; Baldus SE; Cooc J; Azuma M; Metzger R; Hoelscher AH; Danenberg KD; Prenzel KL; Danenberg PV
Neoplasia; 2008 Jul; 10(7):674-9. PubMed ID: 18592007
[TBL] [Abstract] [Full Text] [Related]
5. Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas.
Couvelard A; O'Toole D; Leek R; Turley H; Sauvanet A; Degott C; Ruszniewski P; Belghiti J; Harris AL; Gatter K; Pezzella F
Histopathology; 2005 Jun; 46(6):668-76. PubMed ID: 15910598
[TBL] [Abstract] [Full Text] [Related]
